Literature DB >> 18656448

Identification of TRIM22 as a RING finger E3 ubiquitin ligase.

Zhijian Duan1, Bo Gao, Wei Xu, Sidong Xiong.   

Abstract

TRIM22, a member of the TRIM family proteins which contain RING finger, B-box, and coiled-coil domains, has been reported as a transcriptional regulator and involved in various cellular processes. In this study, the E3 ubiquitin ligase activity, a novel property of TRIM22, was demonstrated. It was found that TRIM22 underwent self-ubiquitylation in vitro in combination with the E2 enzyme UbcH5B and the ubiquitylation was dependent on its RING finger domain. Further evidences showed that TRIM22 could also be self-ubiquitylated in vivo. Importantly, TRIM22 was conjugated with poly-ubiquitin chains and stabilized by the proteasome inhibitor in 293T cells, suggesting that TRIM22 targeted itself for proteasomal degradation through the poly-ubiquitylation. We also found that TRIM22 was located in the nucleus, indicating that TRIM22 might function as a nuclear E3 ubiquitin ligase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18656448     DOI: 10.1016/j.bbrc.2008.07.070

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  The E3 Ubiquitin Ligase TBK1 Mediates the Degradation of Multiple Picornavirus VP3 Proteins by Phosphorylation and Ubiquitination.

Authors:  Dan Li; Wenping Yang; Jingjing Ren; Yi Ru; Keshan Zhang; Shaozu Fu; Xiangtao Liu; Haixue Zheng
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

2.  TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.

Authors:  Anna Kajaste-Rudnitski; Sara S Marelli; Cinzia Pultrone; Thomas Pertel; Pradeep D Uchil; Nadir Mechti; Walther Mothes; Guido Poli; Jeremy Luban; Elisa Vicenzi
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

3.  Estrogen induced breast cancer is the result in the disruption of the asymmetric cell division of the stem cell.

Authors:  Jose Russo; Kara Snider; Julia S Pereira; Irma H Russo
Journal:  Horm Mol Biol Clin Investig       Date:  2010-01-01

4.  Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.

Authors:  Qi Li; Cheng Hiang Lee; Lauren A Peters; Lucas A Mastropaolo; Cornelia Thoeni; Abdul Elkadri; Tobias Schwerd; Jun Zhu; Bin Zhang; Yongzhong Zhao; Ke Hao; Antonio Dinarzo; Gabriel Hoffman; Brian A Kidd; Ryan Murchie; Ziad Al Adham; Conghui Guo; Daniel Kotlarz; Ernest Cutz; Thomas D Walters; Dror S Shouval; Mark Curran; Radu Dobrin; Carrie Brodmerkel; Scott B Snapper; Christoph Klein; John H Brumell; Mingjing Hu; Ralph Nanan; Brigitte Snanter-Nanan; Melanie Wong; Francoise Le Deist; Elie Haddad; Chaim M Roifman; Colette Deslandres; Anne M Griffiths; Kevin J Gaskin; Holm H Uhlig; Eric E Schadt; Aleixo M Muise
Journal:  Gastroenterology       Date:  2016-02-04       Impact factor: 22.682

5.  TRIM22: A Diverse and Dynamic Antiviral Protein.

Authors:  Clayton J Hattlmann; Jenna N Kelly; Stephen D Barr
Journal:  Mol Biol Int       Date:  2012-05-08

6.  Enterovirus 71 induces degradation of TRIM38, a potential E3 ubiquitin ligase.

Authors:  Xinlei Liu; Xiaobo Lei; Zhuo Zhou; Zhenmin Sun; Qinghua Xue; Jianwei Wang; Tao Hung
Journal:  Virol J       Date:  2011-02-10       Impact factor: 4.099

7.  DECODE: an integrated differential co-expression and differential expression analysis of gene expression data.

Authors:  Thomas W H Lui; Nancy B Y Tsui; Lawrence W C Chan; Cesar S C Wong; Parco M F Siu; Benjamin Y M Yung
Journal:  BMC Bioinformatics       Date:  2015-05-31       Impact factor: 3.169

8.  In silico analysis of functional single nucleotide polymorphisms in the human TRIM22 gene.

Authors:  Jenna N Kelly; Stephen D Barr
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

9.  Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A.

Authors:  Chen Yang; Xinhao Zhao; Dakang Sun; Leilei Yang; Chang Chong; Yu Pan; Xiumei Chi; Yanhang Gao; Moli Wang; Xiaodong Shi; Haibo Sun; Juan Lv; Yuanda Gao; Jin Zhong; Junqi Niu; Bing Sun
Journal:  Cell Mol Immunol       Date:  2015-02-16       Impact factor: 11.530

10.  TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.

Authors:  Andrea Di Pietro; Anna Kajaste-Rudnitski; Alexandra Oteiza; Lucia Nicora; Greg J Towers; Nadir Mechti; Elisa Vicenzi
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.